Hypertension control
The largest controllable mortality risk is a primary-care delivery failure, not a missing drug.
The scale of it
adults aged 30-79 with hypertension
The summary lives here. The full whitepaper walks through the four-axis ranking, existing alternatives, proposed direction, cost & scale, and suggested investors — in the spirit of Hyperloop Alpha.
Quantity · humans affected
Severity · WTP / wealth
share of affected person’s wealth they would pay for a solution
Current solutions
quality of existing solutions — low score = high opportunity
Time · OOM to impact
order-of-magnitude horizon to civilizational-scale impact
Priority score
63
importance × urgency, 0–100
Importance
69
humans affected × severity, gated by market
Urgency
91
direction of travel + solution gap
Neglectedness
6/10The drug classes and clinical knowledge are well supplied, but the delivery system is not: 99 of 195 countries and territories have control rates below 20%, and only 28% of low-income countries report general availability of all WHO-recommended medicines.
highTractability
9/10Validated devices, low-cost medicines, standardized protocols, team-based care, and monitoring systems already exist. WHO estimates that controlling half of affected people could prevent 76M deaths by 2050.
highWays to help
Build measurement quality assurance, medicine-availability tooling, patient registries, and follow-up workflows for accountable primary-care networks.
Work in primary care, public-health implementation, medicine procurement, or cardiovascular outcomes measurement.
Organizations
- WHO HEARTSglobal implementation program
- Resolve to Save Livesnonprofit
- Bloomberg Philanthropiesfunder
People to follow
- Tom Friedenfounder and CEO, Resolve to Save Lives
Three-lens scoring
Hypertension is persistently high pressure in the arteries. It usually causes no symptoms while it damages blood vessels, the heart, brain, and kidneys, increasing the risk of heart attack, stroke, heart failure, chronic kidney disease, and dementia. WHO estimates that 1.4 billion adults aged 30 to 79 had hypertension in 2024, but only 320 million, 23 percent, had it controlled. The core interventions already exist: validated blood-pressure devices, standardized treatment protocols, inexpensive medicines, team-based primary care, reliable refills, and population registries. The unsolved problem is making that complete control loop dependable for every patient.
The success vision · 10 years horizon
If we solve this, here is the world we get.
Before · today
1.4B adults live with hypertension; about 600M are unaware and only 23% have it controlled. Measurement, medicines, follow-up, and data routinely fail as one disconnected chain.
After · 10 years
Validated measurement, clinician-approved protocols, uninterrupted medicine supply, and active follow-up produce sustained majority control in every participating care network.
Companies on this quest
0 mappedNo companies mapped yet. Known gap.
Capital funding this quest
0 allocatorsNo allocators mapped yet. Known gap.
Writing about this right now
full feed →No coverage logged yet. The next ingest cron will populate this.